This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Peter Wayne Marks
Introduction
Peter Wayne Marks is a notable inventor based in Woodbridge, CT (US). He has made significant contributions to the field of medicine, particularly in the treatment of neuroendocrine tumors. His innovative approach has garnered attention in the medical community.
Latest Patents
Peter Wayne Marks holds a patent for a method of treating endocrine tumors through the administration of an mTOR inhibitor, optionally in combination with another drug. This patent represents a crucial advancement in cancer treatment, providing new hope for patients suffering from neuroendocrine tumors. He has 1 patent to his name.
Career Highlights
Throughout his career, Marks has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development and treatment methodologies.
Collaborations
Peter has collaborated with notable professionals in his field, including David E. Lebwohl and David Lebwohl. These partnerships have contributed to the advancement of his research and the successful implementation of his patented methods.
Conclusion
Peter Wayne Marks is a distinguished inventor whose work in neuroendocrine tumor treatment exemplifies innovation in medicine. His contributions continue to impact the field positively, offering new solutions for challenging medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile